TRANSCUTANEOUS DRUG-DELIVERY - A PRACTICAL REVIEW

被引:49
作者
BERTI, JJ
LIPSKY, JJ
机构
[1] MAYO CLIN & MAYO FDN,DEPT PHARM,CLIN PHARMACOL UNIT,ROCHESTER,MN 55905
[2] MAYO CLIN & MAYO FDN,DEPT INTERNAL MED,ROCHESTER,MN 55905
关键词
D O I
10.4065/70.6.581
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To describe the advantages, disadvantages, practical considerations, and future developments of transcutaneous drug delivery. Material and Methods: The physiochemical properties of the drug preparation that are factors in the effectiveness of transcutaneous transport are drug stability or volatility, use of a solvent carrier or vehicle, use of a penetration enhancer, and type of delivery device, Because a drug should remain on the skin without evaporating or becoming otherwise inactive, it is suspended in a vehicle-any gel, lotion, or paste used to apply the drug to the skin, Penetration enhancers include several compounds that are mixed into vehicles to alter the molecular environment of the epidermis and facilitate absorption, The delivery system itself occasio;nally proves to be the ultimate determinant of transdermal drug flow. Results: The advantages of transcutaneous drug delivery are avoidance of the gastrointestinal tract and hepatic first-pass biotransformation acid metabolism, control of absorption, availability of multiple skin sites to avoid local irritation and toxicity, and improved patient compliance, The disadvantages include the potential for localized irritant and allergic cutaneous reactions, systemic toxicity, and difficulties associated with the time necessary for a drug to diffuse through the skin. Conclusion: Transdermal drug regimens are safe and effective, They provide clinicians the opportunity to offer more therapeutic options to their patients to optimize their care.
引用
收藏
页码:581 / 586
页数:6
相关论文
共 42 条
  • [31] Lowenthal DT, Saris S, Paran E, Cristal N, Sharif K, Bies C, Et al., Efficacy of clonidinc as transdermal therapeutic system: the international clinical trial experience, Am Heart J, 112, pp. 893-900, (1986)
  • [32] Loper KA, Ready LB, Dorman BH, Prophylactic transdermal scopolamine patches reduce nausea in postoperative patients receiving epidural morphine, Ancsth Analg, 68, pp. 144-146, (1989)
  • [33] Steingold KA, Laufer L, Chetkowski RJ, DeFazio JD, Matt DW, Meldrum DR, Et al., Treatment of hot flashes with transdermal estradiol administration, J Clin Endocrinol Metab, 61, pp. 627-632, (1985)
  • [34] Gourlay GK, Kowalski SR, Plummer JL, Cherry DA, Szekely SM, Mather LE, Et al., The efficacy of transdermal fentanyl in the treatment of postoperative pain: a double-blind comparison of fentanyl and placebo systems, J Clin Endocrinol Metab, 40, pp. 21-28, (1990)
  • [35] Schaer DH, Buff LA, Katz RJ, Sustained antianginal efficacy of transdermal nitroglyccrin patches using an overnight 10-hour nitrate-free interval, Am J Cardiol, 61, pp. 46-50, (1988)
  • [36] Abelin T, Ehrsam R, Buhler-Reichert A, Imhof PR, Mullcr P, Thommen A, Et al., Effectiveness of a transdermal nicotine system in smoking cessation studies, Methods Find Exp Clin Pharmacol, 11, pp. 205-214, (1989)
  • [37] Scki T, Toeda C, Kawaguchi T, Juni K, Sugibayashi K, Morimoto Y, Enhanced transdermal delivery of zidovudine in rats and human skin, CHEMICAL & PHARMACEUTICAL BULLETIN, 38, pp. 3086-3089, (1990)
  • [38] Levy A, Brandeis R, Treves TA, Meshulam Y, Mawassi F, Feiler D, Et al., Transdermal physostigmine in the treatment of Alzheimer's disease, Alzheimer Dis Assoc Disord, 8, pp. 15-21, (1994)
  • [39] Kim A, Green PG, Rao G, Guy RH, Convective solvent flow across the skin during iontophoresis, Pharm Res, 10, pp. 1315-1320, (1993)
  • [40] Green PG, Hinz RS, Kim A, Szoka FC, Guy RH, Iontophoretic delivery of a series of tripeptides across the skin in vitro, Pharm Res, 8, pp. 1121-1127, (1991)